Omada Health

📊 New findings reveal that sustaining weight loss and overall well-being requires support beyond GLP-1 medications. Our survey of 1,000 non-Omada GLP-1 for weight loss users found that: 💡Only 18% achieved their weight loss goals before discontinuing. 💡66% of participants regained weight after stopping the medication. Given this rate of short-lived persistence, the question becomes: How can we set patients up for success with weight management after discontinuing their medication? Learn more about our insights into the patient journey: https://lnkd.in/eUY3Z5EY

Research shows that diabetes and cardiometabolic conditions, such as hypertension, are some of the top clinical concerns from employers. So what options are they choosing to help? According to Truist Securities, Omada is a top choice for employers considering digital diabetes, hypertension, and weight management programs. We’d like to think it’s because we’re delivering what benefit buyers want: ❗An engaging benefit that people will use ❗Clinically validated care and improved outcomes ❗Savings - because of the squeeze that cardiometabolic disease can have on their budgets. Interested in learning more? Check out our latest report on how we measure value: https://lnkd.in/d6dk4QFj

We believe human relationships and empathy are fundamental drivers of sustainable behavior change - to help members reach results that last a long time. Successful weight management requires embracing enduring behavioral changes rather than relying on the latest fad diet. However, changing behavior can be a complex endeavor based on the individual’s personal barriers. Learn more about the principles of sustained weight health, and why support is important: https://lnkd.in/es2VhXxM

We're #hiring! Join us on our mission to inspire and engage people in lifelong health, one step at a time. Apply today or share this post with your network.

We're #hiring! Join us on our mission to inspire and engage people in lifelong health, one step at a time. Apply today or share this post with your network.

🚀 Omada Health is doubling down on our promise to complete, not compete with primary care. Our new research with Stanford Healthcare AI Applied Research Team (HEA3RT) is inspiring. Findings include: 👩⚕️ Majority of providers believe there’s a role for virtual care programs 🤝 76% of providers expressed confidence in recommending virtual care programs 📈 82% are likely to use biometric data from outside sources, like virtual care programs We're in it to enrich patient care, alongside the providers who provide in-person care. Ready for a deep dive? ↪️ Read the findings here: https://lnkd.in/dd6MjeqR

Navigating weight loss with GLP-1s involves more than just medication; it's a journey requiring robust support systems for ongoing success. Carolyn Bradner Jasik, MD, Chief Medical Officer at Omada, emphasizes the critical role of behavioral health in her latest article with Employee Benefit News. Omada's program is tailored to fill this support gap, ensuring patients have the necessary tools to manage both their physical and mental health challenges effectively. By integrating care teams that include behavioral health specialists, we're setting a new standard for patient success on GLP-1 medications. Read about the meaningful impact of added support for those taking GLP-1s: https://lnkd.in/e2zy5EXv

Happy Thanksgiving from our family to yours! We hope you all enjoy relaxing time away from work and with loved ones. We're so grateful to all our employees, members and customers. What are you grateful for? #HappyThanksgiving

It’s about more than the weight loss or reduced A1C, it’s about helping our members build their confidence through the compassion from our expert care team. Omada Health offers chronic condition care at scale, utilizing the time between doctor’s visits to help make improvements in health outcomes for your population. Learn more about what we offer: https://lnkd.in/ekgvVSKW

“We have a human at the center of our care paradigm.”  - Terry Miller, Omada's VP of Machine Learning, AI and Data Science Strategy In a recent interview with The Chief AI Officer Show, Terry shares his own career journey, breaks down what he expects to see in the future of AI, and showcases Omada’s philosophy of utilizing AI as an augmentative tool rather than a replacement. Check out the full interview 👇